Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

D.C. PBM "Transparency" Provision Temporarily Blocked By Court

This article was originally published in The Pink Sheet Daily

Executive Summary

Federal judge grants the Pharmaceutical Care Management Association's request to preliminarily enjoin enforcement of a law requiring broad disclosure of pharmacy benefit managers' financial agreements. PCMA demonstrated a "likelihood of success" on its claim that the law violates the Constitution's Takings Clause, the court says.

You may also be interested in...



Maine PBM Law Clears Hurdle; Magistrate Judge Recommends Lifting Injunction

If approved, the decision would allow implementation of law requiring PBM transparency of rebates and other financial arrangements. Magistrate judge says law would not automatically result in regulatory "taking" of trade secrets. PCMA will seek full review by the district court.

Maine PBM Law Clears Hurdle; Magistrate Judge Recommends Lifting Injunction

If approved, the decision would allow implementation of law requiring PBM transparency of rebates and other financial arrangements. Magistrate judge says law would not automatically result in regulatory "taking" of trade secrets. PCMA will seek full review by the district court.

PCMA Challenges D.C.'s PBM "Transparency" Provision In Federal Court

The PBM association's arguments against Title II of D.C.'s "AccessRx Act of 2004" mirror those made in a similar case in Maine. PCMA contends that the law, which requires PBMs to disclose financial arrangements with drug manufacturers, is unconstitutional and preempted by ERISA.

Topics

UsernamePublicRestriction

Register

ID1132115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel